AstraZeneca: ‘Firing On All Cylinders’ In Q3

But UK Drug Maker Warns China Growth Will Now Slow

 
• By Sten Stovall

AstraZeneca beat market forecasts when posting its fifth successive quarter of revenue growth – but the UK drug maker warned that its sales in China will now slow down.

UK-Flag_Astrazeneca
AstraZeneca lifted its full-year sales guidance again as key oncology drugs stayed strong • Source: Shutterstock

More from Business

More from Scrip